Damora Therapeutics, Inc. (DMRA) › Operating IncomeDamora Therapeutics, Inc. (DMRA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: $38.97M2020: -$33.64M2021: -$52.23M2022: -$61.21M2023: -$39.91M2024: -$22.26M2025: -$210.87M-$210.87M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$210.87M-847.3%2024-$22.26M+44.2%2023-$39.91M+34.8%2022-$61.21M-17.2%2021-$52.23M-55.3%2020-$33.64M-186.3%2019$38.97M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share